| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.0052 | 1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.0083 | 1 |